Literature DB >> 1137769

Migraine in general practitioners.

W E Waters.   

Abstract

A self-administerd questionnaire was posted to 1 129 medical general practitioners in an urban and in a rural area of England. The prevalences of headache, and of the features of migraine, in the year immediately preceding the survey were similar in the two areas. After allowing for the different age and sex composition of the populations, these prevalences were also similar to those found in the general population during an early survey in Wales. About 13% of the male and 25% of the female general practitioners thought that they had had migraine in the previous year. There was little evidence that doctors with 'classic' migraine differed from those with 'common' migraine in the proportion who experienced other migrainous features (unilateral distribution of headache and accompanying nausea) or in their response to treatment with ergotamine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137769      PMCID: PMC478886          DOI: 10.1136/jech.29.1.48

Source DB:  PubMed          Journal:  Br J Prev Soc Med        ISSN: 0007-1242


  4 in total

1.  Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives.

Authors:  M A Barrie; W R Fox; M Weatherall; M I Wilkinson
Journal:  Q J Med       Date:  1968-04

2.  Prevalence and heredity of migraine and migrainoid headaches among 461 Danish doctors.

Authors:  T Dalsgaard-Nielsen; J Ulrich
Journal:  Headache       Date:  1973-01       Impact factor: 5.887

3.  Headaches and migraine in colour retouchers.

Authors:  P J Taylor; S J Pocock; S A Hall; W E Waters
Journal:  Br J Ind Med       Date:  1970-10

4.  Epidemiology of headache and migraine in women.

Authors:  W E Waters; P J O'Connor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-04       Impact factor: 10.154

  4 in total
  1 in total

1.  Migraine and non-migrainous headaches. A community survey in Jerusalem.

Authors:  J H Abramson; C Hopp; L M Epstein
Journal:  J Epidemiol Community Health       Date:  1980-09       Impact factor: 3.710

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.